144Filing Date: Aug 14, 2026

AbbVie

Insider Proposed Sale Notice

View SEC Filing
ACC: 0001950047-26-008158

Sale Plan

NICHOLAS DONOGHOE
Officer·AbbVie
Proposed
CommonNYSE
Shares32.71K
Est. DateAug 14
Market Value$8.18M
BrokerMorgan Stanley Smith Barney LLC Executive Financial Services
AcquisitionStock Option Exercise · Issuer
Acquired DateAug 14, 2026
Amount Acquired32.71K
% Outstanding0.0019%
Exercise / Payment Details
Paid: Aug 14, 2026Method: Cash
No sales in the past 3 months
Signature & Compliance expand_more
Notice DateAug 14, 2026
Signature /s/ Nicholas Jason Donoghoe
Issuer Info expand_more
CompanyABBVIE INC.
CIK0001551152
SEC File No.001-35565
Phone847-932-7900
Address1 North Waukegan Road, North Chicago, IL 60064-6400

keid analysis is for reference only and does not constitute investment advice.